Heather Feigelson to Cardiovascular Diseases
This is a "connection" page, showing publications Heather Feigelson has written about Cardiovascular Diseases.
Connection Strength
0.179
-
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. J Natl Cancer Inst. 2024 Aug 01; 116(8):1384-1394.
Score: 0.162
-
Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 Feb 06; 326(6):381-6.
Score: 0.017